• Interleukin 2 (IL2) Soluble Receptor Alpha
  • West Nile Virus (WNV) Antibody, IgG and IgM, CSF
  • Colorectal Cancer Gene Mutation and Methylation Panel, NGS (OptiSeq™, Shield™)
  • Serine Peptidase Inhibitor, Kazal type 1 (SPINK1) Gene Mutation Analysis for Pancreatitis
  • Angiotensin Converting Enzyme (ACE), CSF
  • Mucolipidosis type IV
  • Biliary Tract Malignancy, FISH
  • Complement Component C3, Serum
  • Acetoacetate (Ketones), Urine
  • Lipoprotein Associated Phospholipase A2 Activity
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /OvaWatch, Multiplex Biomarker for Ovarian cancer Risk Assessment
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

OvaWatch, Multiplex Biomarker for Ovarian cancer Risk Assessment
Medical Test

Turnaround Time
Access to OvaWatch, Multiplex Biomarker for Ovarian cancer Risk Assessment is restricted.
Loading...